Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
CFD-H5256 | Human | Human Complement Factor D / CFD Protein, Fc Tag |
|
||
CFD-R5255 | Rhesus macaque | Rhesus macaque Complement Factor D / CFD Protein, Fc Tag |
|
||
CFD-R52H3 | Rhesus macaque / Cynomolgus | Rhesus macaque / Cynomolgus Complement Factor D / CFD Protein, His Tag (active enzyme) |
|
||
CFD-H52H8 | Human | Human Complement Factor D / CFD Protein, His Tag (active enzyme) |
|
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Danicopan | ACH-4471; ACH-0144471; ALXN-2040; ACH-CFDIS | Approved | Achillion Pharmaceuticals Inc | Voydeya, VOYDEYA | Japan | Hemoglobinuria, Paroxysmal | Alexion Pharmaceuticals Inc | 2024-01-18 | Hemoglobinuria, Paroxysmal; Coronavirus Disease 2019 (COVID-19); Glomerulonephritis, Membranoproliferative; Hepatic Insufficiency; Geographic Atrophy; Glomerulonephritis | Details |
Danicopan | ACH-4471; ACH-0144471; ALXN-2040; ACH-CFDIS | Approved | Achillion Pharmaceuticals Inc | Voydeya, VOYDEYA | Japan | Hemoglobinuria, Paroxysmal | Alexion Pharmaceuticals Inc | 2024-01-18 | Hemoglobinuria, Paroxysmal; Coronavirus Disease 2019 (COVID-19); Glomerulonephritis, Membranoproliferative; Hepatic Insufficiency; Geographic Atrophy; Glomerulonephritis | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Vemircopan | ACH-0145228; ACH-5228; ALXN-2050 | Phase 2 Clinical | Achillion Pharmaceuticals Inc | Myasthenia Gravis; Glomerulonephritis, IGA; Hemoglobinuria, Paroxysmal; Kidney Diseases; Lupus Nephritis; Hepatic Insufficiency | Details |
BCX-9930 | BCX-9930 | Phase 2 Clinical | Biocryst Pharmaceuticals Inc | Hemoglobinuria, Paroxysmal; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulonephritis | Details |
ACH-5548 | ACH-5548; ACH-0145548 | Phase 1 Clinical | Achillion Pharmaceuticals Inc | Autoimmune Diseases | Details |
BCX-10013 | BCX-10013 | Phase 1 Clinical | Biocryst Pharmaceuticals Inc | Hemoglobinuria, Paroxysmal | Details |
ALXN-2080 | ALXN-2080 | Phase 1 Clinical | Alexion Pharmaceuticals Inc | Details | |
Vemircopan | ACH-0145228; ACH-5228; ALXN-2050 | Phase 2 Clinical | Achillion Pharmaceuticals Inc | Myasthenia Gravis; Glomerulonephritis, IGA; Hemoglobinuria, Paroxysmal; Kidney Diseases; Lupus Nephritis; Hepatic Insufficiency | Details |
BCX-9930 | BCX-9930 | Phase 2 Clinical | Biocryst Pharmaceuticals Inc | Hemoglobinuria, Paroxysmal; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulonephritis | Details |
ACH-5548 | ACH-5548; ACH-0145548 | Phase 1 Clinical | Achillion Pharmaceuticals Inc | Autoimmune Diseases | Details |
BCX-10013 | BCX-10013 | Phase 1 Clinical | Biocryst Pharmaceuticals Inc | Hemoglobinuria, Paroxysmal | Details |
ALXN-2080 | ALXN-2080 | Phase 1 Clinical | Alexion Pharmaceuticals Inc | Details |
This web search service is supported by Google Inc.